ABSTRACT
Silibinin is a natural flavonoid with anti-diabetic activity. Glucagon-like peptide−1 (GLP−1), an intestinal hormone mainly secreted from L cells, which regulates insulin production and sensitivity, appears to be a potential therapeutic strategy for T2DM. The current study aims to determine the protective effect of silibinin against palmitic acid (PA)-induced damage in GLUTag cells. The results revealed that PA triggered endoplasmic reticulum (ER) stress and apoptosis in GLUTag cells, while silibinin attenuated PA-induced lipotoxicity. Based on the estrogen-like effects of silibinin and the role of estrogen receptors in regulating glycolipid metabolism, the involvement of estrogen receptors in the protective effects of silibinin in GLUTag cells was further investigated. The results showed that estrogen receptor α- and β-specific inhibitors reversed the inhibitory impact of silibinin on ER stress. Our study demonstrated that silibinin protects GLUTag cells from PA-induced injury by decreasing ER stress under the regulation of estrogen receptors α and β.
Acknowledgements
We thank Dr. Daniel J. Drucker of The University of Toronto for kindly providing GLUTag cell line.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Author contribution
Conceptualization, X.S., C.C. and F.X.; methodology, X.L., L.Z. and F.X.; data collection, X.S., C.C., X.L. and L.Z.; validation, X.Z. and N.C.; formal analysis, W.L., Z.J. and C.C.; writing-original draft preparation, X.S., C.C. and L.Z.; writing-review and editing, F.X. and T.I.; funding acquisition, F.X.; supervision, F.X. and T.I. All authors have read and agreed to the published version of the manuscript. All data were generated in-house. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy.